Intelence and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Intelence (etravirine), especially for people who are male, 60+ old, have been taking the drug for 5 - 10 years also take Isentress, and have Atypical mycobacterial infection.

The phase IV clinical study analyzes which people have Heart attack when taking Intelence. It is created by eHealthMe based on reports of 3,739 people who have side effects when taking Intelence from the FDA, and is updated regularly.

What is Intelence?

Intelence has active ingredients of etravirine. It is often used in hiv infection. eHealthMe is studying from 3,797 Intelence users. Check the latest studies of Intelence.

What is Heart attack?

Heart attack is found to be associated with 2,483 drugs and 3,296 conditions by eHealthMe. Check the latest studies of Heart attack.

On Jul, 15, 2026

3,739 people reported to have side effects when taking Intelence.
Among them, 45 people (1.2%) have Heart attack.

Among these 45 people:

How long have people been on Intelence when they have Heart attack? *

What is the gender of people who have Heart attack when taking Intelence? *

female: 4.55 %
male: 95.45 %

What is the age of people who have Heart attack when taking Intelence? *

What are other drugs people take besides Intelence? *

What are other side effects people have besides Heart attack? *

Septic Shock (shock due to blood infection): 6 people, 13.33%
Myocarditis (inflammation of heart muscle myocardium): 6 people, 13.33%
Chest Pain: 5 people, 11.11%
Pain: 5 people, 11.11%
Acute Kidney Failure: 4 people, 8.89%
Cardiac Failure Acute: 4 people, 8.89%
Cardiac Failure: 3 people, 6.67%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 3 people, 6.67%
Fatigue (feeling of tiredness): 3 people, 6.67%
Impaired Work Ability: 3 people, 6.67%

What are the existing conditions these people have? *

Atypical Mycobacterial Infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis): 4 people, 8.89%
High Blood Pressure: 3 people, 6.67%
Pain: 3 people, 6.67%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 6.67%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 2 people, 4.44%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 2.22%
Chronic Renal Failure (kidney failure): 1 person, 2.22%
Constipation: 1 person, 2.22%
Depression: 1 person, 2.22%
Diabetes: 1 person, 2.22%

* Approximation only. Some reports may have incomplete information.

Do you take Intelence and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Intelence:

Intelence (3,797 reports)

Heart attack treatments and more:

Heart attack (266,145 reports)

Browse all side effects of Intelence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Heart attack (2,483 drugs)

Browse all the conditions that are associated with Heart attack:

Heart attack (3,296 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etravirine (the active ingredients of Intelence) and Intelence (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.